News for 'Biotech Engineering'

How long before the world gets a COVID-19 vaccine?

How long before the world gets a COVID-19 vaccine?

Rediff.com28 Apr 2020

More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization, there are now more than 70 potential vaccines under evelopment, with some already in clinical trials.

CBSE puts class XII sample papers on its site

CBSE puts class XII sample papers on its site

Rediff.com15 Dec 2011

The CBSE has mounted 32 sample papers of Class XII and of 28 other examinations on its website and students can download them free.

COVID-19 vaccine race: Where they stand currently

COVID-19 vaccine race: Where they stand currently

Rediff.com9 Jan 2021

As India prepares to launch its vaccine drive on January 16, here is a look at the options:

KPO biz to touch $10 bn by 2012: Assocham

KPO biz to touch $10 bn by 2012: Assocham

Rediff.com23 Dec 2010

Currently, the KPO market size is estimated to be about $5.5 billion and the sector is growing by about 15-17 per cent, dominated by professionals belonging to fields such as management, medical and engineering, the chamber said.

Hiring activities see uptick in July

Hiring activities see uptick in July

Rediff.com12 Aug 2020

The phased reopening and regulated relaxations of many key industries have paved the way for a slight recovery in hiring activities but hiring is still down by 47 per cent in July 2020 compared to the same month last year.

GM crops: India's testing norms insufficient

GM crops: India's testing norms insufficient

Rediff.com28 Jan 2010

The current testing norms to rule out harmful effects of genetically modified crops like Bt-brinjal are far from being fool proof, a member of biotech regulator GEAC said.

It's go-slow on campus job placements!

It's go-slow on campus job placements!

Rediff.com15 Nov 2019

'Zero Day' visitors like Maruti Suzuki, TVS, Tata Motors, Hero MotoCorp, Ashok Leyland and Bajaj Electricals are visiting fewer campuses.

20 Indian cos in Forbes best under a billion list

20 Indian cos in Forbes best under a billion list

Rediff.com11 Sep 2009

The top 200 companies were picked from over 12,000 publicly-listed firms with sales of less than $1 billion in the Asia-Pacific region.

Bt brinjal safe for all: Chavan

Bt brinjal safe for all: Chavan

Rediff.com19 Jan 2010

Amid a raging debate over release of Bt brinjal for commercial use, Science and Technology Minister Prithviraj Chavan on Tuesday said genetically-tweaked variety of the vegetable was 'safe for all'.

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

IT-BPO firms take KPO route to raise profits

IT-BPO firms take KPO route to raise profits

Rediff.com11 Jan 2008

Nasscom estimates that the KPO industry is poised for a 45 per cent per annum growth till 2010. The current hotspots in KPO are engineering and design, basic data search, integration and management and biotech & pharma.

Four IPOs to hit markets; aims to garner Rs 14,628-cr

Four IPOs to hit markets; aims to garner Rs 14,628-cr

Rediff.com8 Aug 2021

The buzz in the IPO market continues with four companies launching their initial share sales this week to raise over Rs 14,628 crore collectively. This comes after four companies -- Devyani International, Krsnaa Diagnostics, Windlas Biotech and Exxaro Tiles-- launched their initial share-sales last week to mobilise Rs 3,614 crore. So far in the current fiscal, 16 companies have raised Rs 30,666 crore through IPOs against Rs 31,277 crore by 30 firms in the entire 2020-21. Going forward, market analysts expect the IPO environment to remain buzzing during the entire 2021-22.

Studying liberal arts in college is not for losers

Studying liberal arts in college is not for losers

Rediff.com16 Jul 2007

So you've always believed that it's only dimbulbs who opt for arts? Read on to find out why you're wrong.

'Nation building, top priority for IIT-ians'

'Nation building, top priority for IIT-ians'

Rediff.com9 Nov 2006

'IIT-ians want to contribute to nation building and the Pan IIT meet provides a channel to do that. We want to move beyond words and set up an action plan for this,' says Pradeep Gupta.

Biocon shoots magic bullet at cancer

Biocon shoots magic bullet at cancer

Rediff.com18 Sep 2006

An Ill Wind Blowing Over Karnataka

An Ill Wind Blowing Over Karnataka

Rediff.com13 Apr 2022

This divisiveness is upsetting social cohesion and can throw the bright young people thronging to Bengaluru with billion dollar ideas in their creative minds off balance, warns Shekhar Gupta.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

Clinical trials of COVID-19 vaccine show promising early results: Experts

Clinical trials of COVID-19 vaccine show promising early results: Experts

Rediff.com21 May 2020

Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.

Recovered people showing faster response to Covishield: Study

Recovered people showing faster response to Covishield: Study

Rediff.com3 Mar 2021

Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India's corona immunisation cover.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

What's delaying India's STUDY ABROAD plans?

What's delaying India's STUDY ABROAD plans?

Rediff.com29 Jun 2021

Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.

What are the career prospects for design graduates?

What are the career prospects for design graduates?

Rediff.com21 Nov 2015

Overseas education consultant NNS Chandra offers advice on how to pick the right international career.

Modi's 'Make in India' bats for GM food crops

Modi's 'Make in India' bats for GM food crops

Rediff.com29 Nov 2014

This comes despite sharp criticism received from various RSS affiliated organisations

Utah governor presents lifetime achievement award to Dr Dinesh Patel

Utah governor presents lifetime achievement award to Dr Dinesh Patel

Rediff.com27 Dec 2013

Dinesh Patel, Utah's most high profile and influential Indian American, was conferred the Willem J Kolff Lifetime Achievement Award at BioUtah's 2013 Utah Life Science Award, the state's top science award ceremony.

Stocks you must buy, hold or exit

Stocks you must buy, hold or exit

Rediff.com25 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries:

Environment min gives conditional nod to modify food crop

Environment min gives conditional nod to modify food crop

Rediff.com28 Feb 2014

The environment ministry is likely to allow generic modification of food crops.

Should you accumulate this stock for 15-20 years?

Should you accumulate this stock for 15-20 years?

Rediff.com4 Dec 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

When should you take Covishield/Covaxin?

When should you take Covishield/Covaxin?

Rediff.com26 Mar 2021

'You can still acquire the COVID-19 virus even if you are vaccinated.' 'But if you develop the disease, (after being vaccinated) the likelihood is that it will be mild.' 'It just makes sense to continue to take precautions, because you may be around a lot of unvaccinated people.'

A 'corporate hand' behind the 'foreign hand'?

A 'corporate hand' behind the 'foreign hand'?

Rediff.com30 Jun 2014

It is regrettable that the IB has tried to devalue the expertise available both within the concerned ministry and in the scientific community by its allegations. Governments and NGOs in many western nations have not been accused of being 'anti-national' when they put their foot down on questionable practices by cash rich agri-business companies, says Rashme Sehgal.

Making losses in stocks? Here's help

Making losses in stocks? Here's help

Rediff.com21 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries

Bearish trend continues on D-Street; Sensex ends below 27,000

Bearish trend continues on D-Street; Sensex ends below 27,000

Rediff.com3 Jun 2015

Weak monsoon forecast rekindled fears of higher inflation.

'My son wants to pursue MSc in France'

'My son wants to pursue MSc in France'

Rediff.com5 Dec 2015

Overseas education consultant NNS Chandra offers advice on how to pick the right international career

Left, right coming together on GM, PSU land sale

Left, right coming together on GM, PSU land sale

Rediff.com10 Oct 2016

BMS, BKS and SJM are trying to forge common cause with outfits on the other side of the ideological divide over the government's policies they are not in agreement with.

Stocks you must buy, hold or exit in the New Year

Stocks you must buy, hold or exit in the New Year

Rediff.com26 Dec 2019

Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.

How to get a Central government job

How to get a Central government job

Rediff.com28 Jul 2016

In an online chat with readers, Amit Chaudhary from Sarkari Jobs answered queries on how to crack the SSC Combined Graduate Level exam.

'My son wants to pursue MS abroad. Please advice'

'My son wants to pursue MS abroad. Please advice'

Rediff.com25 Jul 2015

Overseas education consultant NNS Chandra offers advice on how to pick the right international education.

From Boston to UP's badlands: She came back to change India

From Boston to UP's badlands: She came back to change India

Rediff.com1 Oct 2014

Nandita Shetty left an exclusive job in Boston behind and moved back to India to participate in the growth story of this country.

World's 10 best performing CEOs

World's 10 best performing CEOs

Rediff.com5 Nov 2014

Amazon CEO Jeff Bezos has been ranked as the world's best performing CEO.

Leaving its troubles behind, Shantha Biotechnics makes a fresh start

Leaving its troubles behind, Shantha Biotechnics makes a fresh start

Rediff.com17 Mar 2015

The biotech company's revenues had fallen to as low as Rs 50 cr.

'How's the job market for MS graduates in the US?'

'How's the job market for MS graduates in the US?'

Rediff.com5 Jun 2015

Overseas education consultant NNS Chandra has answers to all your queries related to pursuing an education abroad.